Introducing PD-L1 (SP142) antibody
from Spring Bioscience

PD-L1 (Programmed Death-Ligand 1) (SP142) Immunostaining in lung squamous cell carcinoma - High PD-L1 protein expression is detected in tumor and infiltrating immune cells

      - Recombinant rabbit monoclonal technology
      - Developed specifically for use in FFPE IHC
      - Highly sensitive & specific
      - No cross-reactivity and minimal background
      - Detects PD-L1 expression in both tumor and immune cells

Spring Bioscience
www.springbio.com
US: spring.orders@ventana.roche.com
INTL: spring.intlorders@ventana.roche.com
Technical Support: spring.tech@ventana.roche.com
Other Information: spring.info@ventana.roche.com
Toll free (800) 787-6896
Tel (925) 474-8440
Fax (925) 474-8469

© 2014 Spring Biosciences, Inc.
All trademarks are the property of their respective owners.

Privacy Policy